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On average, the Peruvian population is among the shortest in the world1. Here we show that
Native American ancestry is associated with reduced height in an ethnically diverse group of
Peruvians, and identify a novel, population-specific, missense variant in FBN1 (E1297G) that is
significantly associated with lower height. Each copy of the minor allele (frequency=4.7%)
reduces height by 2.2 cm (4.4 cm in homozygous individuals). This is the largest effect size known
for a common height-associated variant. FBN1 encodes the extracellular matrix protein fibrillin-1,
a major structural component of microfibrils. We observed less densely packed fibrillin-1-rich
microfibrils with irregular edges in the skin of individuals homozygous for G1297 compared to
individuals homozygous for E1297. Moreover, we show that E1297G locus is under positive
selection in non-African populations, and the E1297 variant shows subtle evidence of positive
selection within the Peruvian population specifically. This variant is also significantly more
frequent in coastal Peruvian populations than in populations from the Andes or the Amazon,
suggesting that short stature might be the result of adaptation to factors associated with the coastal
environment in Peru.

Author Manuscript

With average male and female heights of 165.3 cm and 152.9 cm respectively, Peruvians are
among the shortest people in the world1. The genetic makeup of Peruvians is shaped by
admixture between Native American residents of Peru and the incoming Europeans,
Africans, and Asians who arrived in Peru since the 18th century2,3. A previous study of
height in South and Latin Americans reported that Native American ancestry is correlated
with lower height in these populations4, however, this association may have been the result
of confounding socioeconomic or environmental factors that were not captured by
socioeconomic covariates in that study (education and wealth). Even if the association
between Native American ancestry and height was driven by genetic factors, the specific
genes and adaptive processes remain unclear.

Author Manuscript

In order to define genetic factors contributing to height in Peruvians, we obtained height and
genotyping data from 3,134 individuals in 1,947 households in Lima, Peru (Methods,
Supplementary Information Section 1). We inferred the Native American ancestry
proportion in each individual (Extended Data Figure 1) and observed a negative correlation
between height and Native American ancestry proportion (Pearson’s correlation coefficient
(r)=−0.28, 95% confidence interval (CI)=−0.31–−0.25, p-value=9.3×10−58, Figure 1A,
Supplementary Information section 2). Native American ancestry remained significantly
associated with lower height after adjusting for age, sex, African, and Asian ancestry
proportions and a random household effect, as a proxy for unmeasured environmental
factors (p-value=7.2×10−43, effect size=−14.75 cm for 100% Native American versus 100%
European ancestry, standard error (se)=1.06, Figure 1B).
To identify variants deriving this effect, we performed a genome-wide association study
(GWAS). We observed association at five highly linked SNPs within a single locus
overlapping FBN1 (15q21.1, p-value<5×10−8, Extended Data Figure 2A). One SNP,
rs200342067 (minor allele frequency (MAF)=4.72%, effect size=−2.22 cm, se=0.36, pvalue=6.8×10−10), is a missense variant (E1297G) while the other four are intronic (Figure
1C, Extended Data Table 1). Accounting for additional covariates, such as population PCs or
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identity-by-descent5, did not impact the association results (Supplementary Information
Section 3).

Author Manuscript

To replicate this association, we genotyped an independent cohort of Peruvians (N=598,
Methods, Supplementary Information Section 1) and observed a similar allele frequency and
effect size for rs200342067 in the replication cohort (MAF=4.52%, effect size=−1.70 cm,
se=0.82, p-value=0.04, Table 1). Meta-analysis of the discovery and replication cohorts
increased the association’s significance (effect size=−2.14 cm, se=0.33, p-value=9.2×10−11,
Table 1). We also tested association of rs200342067 with inverse normally transformed
height in GIANT6 and PAGE7, two publicly available datasets of Hispanic/Latino
individuals. While allele frequencies were lower in these datasets (<1.15%), we observed
similar effect sizes across cohorts (effect size (se) for discovery, replication, PAGE, and
GIANT cohorts respectively: −0.25 (0.04), −0.20 (0.10), −0.12 (0.07), and −0.44 (0.22);
Table 1). Meta-analysis of these cohorts further augmented association’s strength (effect
size=−0.22 (se=0.03), p-value=9.8×10−12, Table 1, Figure 1D). These results confirm that
the association between rs200342067 and height is not driven by statistical fluctuation or
genotyping artifact specific to the discovery cohort. We did not find any additional
association in gene-based analysis of rare (MAF<1%) or common variants (Supplementary
Information Section 4).

Author Manuscript

Previous large-scale height GWAS, done predominantly in Europeans, have identified 3,290
independent common height-associated variants8. To assess the predictive power of these
European-biased variants in the Peruvian population we generated polygenic risk scores
(PRS) using conditional effect sizes of 2,993 common height-associated variants that were
present in our cohort (Methods, Supplementary Information Section 5). Greater PRS values
were associated with increased height (Pearson’s r=0.22, CI=0.18–0.25, p-value=2.7×10−34,
Figure 1E). The estimated genetic heritability (h2g) of height was similar for Peruvians
(h2g=57.6%, se=9.7) and Europeans (h2g=62.5%)9; however, previously identified heightassociated variants explained only 6.1% (CI=4.6–7.8, p-value=6.7×10−45,) of height
phenotypic variance in our cohort compared to 24.6% (CI=22.0–27.2) in the original
European cohort.

Author Manuscript

The lower predictive power of PRS calculated based on a European GWAS in a nonEuropean population might be the result of differences in factors related to population
demography (such as LD, allele frequency, sex, and age composition)10–12, non-transmitted
genetic factors (such as genetic makeup of the parent13 and peers14), non-genetic factors
(such as environmental exposure15), or genetic interaction with non-genetic factors16. In line
with previous reports11,12, we observed that the European-biased PRS explains a higher
proportion of height phenotypic variance in individuals with high European ancestry
proportion compared to the individuals with low European ancestry proportion suggesting
that the reduced effect of PRS in Peruvians may be at least in part related to genetic
differences (Supplementary Information Section 5).
Of previously identified common height-associated variants, 99% have effect sizes <0.5 cm/
allele (Figure 2A). In contrast, rs200342067 reduces height by 2.2 cm/allele and explains
0.9% of height phenotypic variance in our cohort (Extended Data Figure 2B). This effect
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size is comparable to a few other extremely rare (MAF<0.5%) height-associated variants
that are believed to be under purifying selection6,8. In the 1000 Genomes Project17,
rs200342067 is specific to Mexican (MAF=0.78%) and Peruvian (MAF=4.12%)
populations. However, the genomic region overlapping rs200342067 is under hard selective
sweep in certain European, South Asian, East Asian, and South American populations18,19
(Supplementary Information Section 6). This observation led us to the hypothesis that
rs200342067 might have risen in frequency in the Peruvian population as a result of positive
selection.

Author Manuscript

To test this hypothesis, we used the integrated Selection of Allele Favored by Evolution
(iSAFE)20 to search for variants under positive selection in a 1.2Mb region around
rs200342067. The top positive selection signal was from rs12441775 (Figure 2B), an
intronic variant in FBN1 with unknown function. The derived rs12441775*G allele has a
much higher frequency in all non-African populations than African populations (58%
(IQR=51–64) versus 4% (IQR=1–5)17, Extended Data Figure 3). This allele shows evidence
of positive selection (integrated Haplotype Score (iHS)18,19<−2 and Extended Haplotype
Homozygosity21 (EHH)) in European, South Asian, and South American populations
including the Peruvian population (DAF=61%, iHS=−2.16, Figure 2C, Extended Data
Figure 3, Supplementary Information Section 6) suggesting an out-of-Africa positive
selection on rs12441775.

Author Manuscript

Since rs12441775 is located 77kb upstream of rs200342067, we considered that increased
frequency of rs200342067 in Peruvians may be the result of positive selection at
rs12441775. Interestingly, rs12441775*G (derived/major) and rs200342067*C (derived/
minor) alleles are out of phase with each other and rarely co-occur on the same extended
haplotypes. In our cohort, only 3% (9/297) of the haplotypes carrying rs200342067*C
(AF=4.7%) also carry rs12441775*G (AF=64.8%, Figure 2D, Supplementary Information
Section 6). Therefore, positive selection at rs12441775 cannot explain the increased
frequency of rs200342067*C in Peruvians.

Author Manuscript

The presence of strong positive selection at haplotypes carrying rs200342067*T prevents the
detection of potentially weaker selection signals at haplotypes carrying rs200342067*C
using methods such as iHS18 or pairwise nucleotide diversity (π)22. However, if
rs200342067*C is under independent positive selection, the length of haplotypes carrying
this allele is expected to be longer than haplotypes carrying other derived alleles with similar
allele frequencies in neutral regions of the genome23. Indeed, we observed that haplotypes
carrying rs200342067*C are longer than 99.2% of haplotypes carrying similar alleles in the
neutral genomic regions (N=2,380 variants, N=3,134 individuals, Figure 2E, Methods).
Excluding the nine haplotypes that carry both rs200342067*C and rs12441775*G alleles
does not change this result (Extended Data Figure 4). Similarly, haplotypes carrying
rs200342067*C were longer than 100% of haplotypes simulated under a neutral
demographic model that matches Peru’s population history (Methods, Extended Data Figure
5). Altogether, these results suggest that the rs200342067*C is under positive selection
independent of rs12441775*G. Almost all other missense variants in FBN1 are under
purifying selection, causing this gene to have a significantly lower burden of missense
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variants than expected (z-score=5.53, p-value=3.2×10−8, Exome Aggregation Consortium
(ExAC), N=60,706)24.

Author Manuscript

The selection signal at rs200342067*C is weaker than rs12441775*G this difference may be
due to the difference in alleles’s age (484 (CI=373–605) versus 2,382 (CI=2,286–2,479)
generations old25 for rs200342067*C and rs12441775*G respectively). It is also not clear
whether the same evolutionary pressures are driving selection at both alleles. We also note
that the positive selection signal at rs200342067 is weaker than known examples of recent
hard selective sweeps (such as SLC24A5 or LCT)19. While alleles under strong positive
selection have |iHS| values>219, the iHS value for rs200342067 is −1.5. This value is more
extreme than reported19 iHS values of 95.3% variants with similar DAF and local
recombination rate in the Peruvian population (Extended Data Figure 6A). Similarly, EHH
for rs200342067 is more extreme than EHH of 97.5% variants with similar DAF and
recombination rates in our cohort (Extended Data Figure 6B–C).

Author Manuscript

FBN1 is 266kb downstream of SLC24A5 (Figure 1C), a well-known example of positive
selection due to its role in skin pigmentation26,27. However positive selection at
rs200342067 is unlikely to be the result of selection at extended haplotypes carrying
positively selected alleles in SLC24A5 as there is no linkage between variants overlapping
FBN1 and variants overlapping SLC24A5 (r2<0.05). We also investigated the structure of
haplotypes carrying rs1426654*A, a SLC24A5 allele associated with light skin
pigmentation26,28 that is known to be under positive selection29 specifically; we observed
that rs200342067*C and rs1426654*A are out of phase with each other and almost never cooccur on the same extended haplotypes. Only 4% (12/297) of haplotypes carrying
rs200342067*C (AF=4.7%) also carry rs12441775*G (AF=17.9%, Figure 2D,
Supplementary Information Section 6). Moreover, FBN1 and SLC24A5 are in different
topologically associating domains (TADs) suggesting that rs200342067 (or other FBN1
variants) are unlikely to have been selected due to long-range regulatory effects on
SLC24A5.

Author Manuscript

Since adaptation to the local environment can drive dramatic allele frequency shifts, we
compared the frequency of rs200342067 among 150 individuals collected separately from
our cohort through the Peruvian Genome Project3 (PGP) from three different geographical
regions in Peru: Coast (N=46), Amazon (N=28), and Andes (N=76). The rs200342067
variant is more frequent in the Coast compared to the Andes or Amazon (MAF=9.7%, 1.7%,
and 0% respectively, coast vs. non-coast Fisher’s exact test p-value=0.0005, Figure 2F,
Supplementary Information Section 7). Allele frequency differences as extreme as this is
observed in <0.7% of all variants (N=9,381,550 variants, Figure 2F) and in <1.1% of
variants matched on DAF and local recombination rate to rs200342067 (N=2,062 variants,
Extended Data Figure 6D). We also used Bayenv230 to check the deviation of rs200342067
from a neutral population structure model after correction for population structure. The
deviation of rs200342067 from the neutral population structure was more extreme than
91.7% of variants in the same DAF and recombination bin (Extended Data Figure 6E,
Methods). Among coastal populations, the Moches population, native to the North coast of
Peru, had an especially high frequency of rs200342067 (N=21, minor allele count=4,
MAF=9.5%). Notably, the average height of Moches people is far below Peru’s average
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height (158 cm and 147 cm for Moches male and female31 versus 164 cm and 152 cm for
Peruvian male and female in the same year1), suggesting rs200342067 may have been
selected as a result of adaptation to factors associated with the coastal environment.
To ensure that the association between rs200342067 and height in the Peruvian population is
not driven by population structure and stratification between individuals from different
geographical regions, we performed a PCA analysis in the PGP cohort3 (N=150) using a
set of common variants (MAF≥5%) and used SNP loadings from the PCA
analysis in the PGP cohort to infer populations PCs in our cohort
(N=3,134, Supplementary Information Section 7, Methods). Correction for these PCs did

Author Manuscript

not change the effect size or the strength of the observed association between rs200342067
and height (N=3,134, MAF=4.72%, effect size=−2.30 cm, se=0.36, p-value=3.0×10−10)
confirming that the observed association between rs200342067 and height is not a result of
confounding population structure.

Author Manuscript

The rs200342067 (E1297G) variant changes the conserved T (major/ancestral) allele to a C
(minor/derived) allele in FBN1 exon 31 (g.48773926T>C, Extended Data Figures 7). This
change substitutes a large, negatively charged glutamic acid for a glycine, the smallest
amino acid in fibrillin-1, encoded by FBN1. Fibrillin-1 is an extracellular matrix (ECM)
glycoprotein that serves as the structural backbone of force-bearing microfibrils in elastic
and non-elastic tissues32 and is also involved in tissue development, homeostasis, and repair
by interacting with transforming growth factor (TGFβ) and other growth factors32. While the
clinical significance of fibrillin-1 E1297G is not known, other fibrillin-1 mutations cause
nine dominantly inherited Mendelian diseases33. Most of these diseases include skeletal
anomalies and changes in skin elasticity33. To investigate possible clinical consequences of
fibrillin-1 E1297G we performed dermatological and rheumatological clinical exams on 11
individuals from our cohort: 2 homozygous (C/C) cases, 2 heterozygous (C/T) cases, and 7
matched controls with reference (T/T) genotype (Methods). While the musculoskeletal
examination revealed no differences between individuals, one C/C genotype individual had
notably thicker skin upon a total body skin examination and appeared older than the stated
age. The other C/C genotype individual had no clinically abnormal cutaneous findings and
none of the C/T or T/T individuals had an abnormal skin exam (Supplementary Information
Section 8).

Author Manuscript

We also obtained skin biopsies from two individuals with rs200342067 C/C genotype
(alternate homozygous) and two with rs200342067 T/T genotypes (reference homozygous,
Methods). We matched each C/C genotype individual with T/T genotype individuals based
on age, sex, and ancestry proportions. Immunohistochemical staining showed that the
individuals with C/C genotype have shorter microfibrillar projections from the dermalepidermal junction into the superficial (papillary) dermis as well as less fibrillin-1 deposition
in the deeper dermis (Extended Data Figure 8, Methods). Scanning electron microscopy
(EM) showed that individuals with C/C genotype have less densely packed microfibrils with
irregular edges and with microfibrils embedded in less dense collagen bundles confirming
the abnormal appearance of fibrillin-1 observed in immunohistochemical analysis of skin
biopsies (Figure 3, Extended Data Figure 9). Together these experiments suggest that
rs200342067 alter the amount and architecture of microfibrillar deposits in the skin.
Nature. Author manuscript; available in PMC 2020 August 06.
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While all the reported fibrillin-1 mutations causing short stature phenotypes occur in the
TGFβ-binding domains, mutations in the cbEGF-domains of fibrillin-1 predominantly lead
to Marfan or Marfan-like syndromes34. Notably, missense mutations in cbEGF-domains 11
to 18 of fibrillin-1 (a.k.a. neonatal region, Extended Data Figure 7) have previously been
associated with severe neonatal forms of Marfan syndrome, mortality within the first two
years of postnatal life, and poor disease prognosis in adults33,35. To our knowledge, E1297G
is the first report of a mutation in the fibrillin-1’s neonatal region that leads to short stature,
in contrast to the tall stature common in Marfan syndrome.

Author Manuscript

E1297G is located in fibrillin-1 calcium binding epidermal growth factor domain 17
(cbEGF-domain 17), between a conserved cysteine (C1296) involved in forming a disulfide
bond with C1284, and a conserved asparagine (N1298) involved in calcium binding36
(Extended Data Figures 7, Supplementary Information Section 8) and may play a role in
calcium-binding37. Calcium binding at fibrillin-1 cbEGF domains stabilizes the protein by
making the microfibrils more rigid and protecting them from degradation by proteases38.
The short fragmented and less packed phenotype seen in the skin of rs200342067 C/C
individuals compared to T/T individuals (Figure 3, Extended Data Figures 8 and 9) might
reflect the higher susceptibility of mutated fibrillin-1 to proteolysis compared to the wildtype protein. The few previous studies that have reported amino acid changes at positions
similar to E1297G in other fibrillin-1 cbEGF-like domains have associated this change with
Marfan syndrome34 highlighting the importance of domain context for studying the
molecular effect of fibrillin-1 mutations39,40. Understanding the cellular mechanisms that
connect E1297G to microfibril structures and height requires further functional follow-up
(Supplementary Information Section 8).

Author Manuscript
Author Manuscript

Common variants with large effect sizes on height might increase in frequency in population
as a result of positive selection. A study of height in Sardinian islanders found an intronic
variant in KCNQ1, which encodes a voltage-gated potassium channel, that reduces height by
an average of 1.8 cm (rs150199504, MAF=7.7%, MAF in Central European population
(CEU)=0.67%); they suggested that this variant is positively selected in Sardinians as a
result of adaptation to the island environment41. A study of signatures of genetic adaptation
in Greenland Inuits found an intronic variant in FADS3, a gene involved in fatty acid
metabolism, that reduces height by 1.9 cm possibly due to the influence of fatty acid
composition on the regulation of growth hormones (rs7115739, DAF=62.7%−81.9%, DAF
in CEU=2.9%−3.6%); they suggested that this variant is positively selected in Greenland
Inuits as a result of adaptation to their fat-rich diet42. Similarly, it is plausible that short
stature in Peruvians is the result of adaptation to the factors associated with the coastal
environment. It is also possible that other FBN1-related traits like changes in cardiovascular
system performance have offered an evolutionary advantage in this population.
Understanding the exact adaptive processes that could have caused the selection of
rs200342067 in the Peruvian population is a challenging task and requires further
investigation.
Besides its implications in medical and population genetics, this study highlights the
importance of large-scale genetic studies in underrepresented and founder populations. Our
findings show that genetic studies in novel populations can uncover novel trait-associated
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variants of large effects in functionally relevant genes. Similar studies in diverse populations
are required to capture the extent of human genetic diversity and to expand the benefits of
genetic research to all human populations.

Methods
Study participants

Author Manuscript

Discovery cohort: The individuals in the discovery cohort (e.g. LIMAA cohort) are a
subset of 4,002 individuals that were collected in Lima, Peru to study the genetics of
tuberculosis in the Peruvian population43. The catchment area included 12 of the 43 districts
of metropolitan Lima, Peru and 3.3 million inhabitants. This catchment area reflects a mix of
urban and peri-urban areas and informal settlements44. Participants were collected in any of
the 106 public health centers in this catchment area. Informed written consent was obtained
from all the participants. The study protocol was approved by the Harvard School of Public
Health’s Institutional Review Board (IRB) and the Research Ethics Committee of the
National Institute of Health of Peru.
Replication cohort: We collected 889 individuals from the same catchment area as the
discovery cohort. Similar to the discovery cohort, we followed the guidelines of the Harvard
School of Public Health’s IRB and the Research Ethics Committee of the National Institute
of Health of Peru guidelines and obtained informed consent from all participants.
Phenotype

Author Manuscript

In both discovery and replication cohorts, height in centimeters was measured by trained
healthcare staff upon recruitment of study participants. We excluded the individuals<19
years of age, individuals without height measurement, and individuals with a measured
height ±3.5 SD away from the population average from the cohort. In addition to height, sex,
age, and individuals’ TB status were also collected. We also collected household-level
socioeconomic factors on housing quality, water supply and sanitation45 and summarized
these factors using principal component analysis (PCA)45 to calculated household-level
composite socioeconomic scores (SES scores). The continuous SES scores were then
categorized into tertiles corresponding to low, middle, and upper socioeconomic groups45.
Genotyping and quality control

Author Manuscript

Discovery Cohort: We collected genotyping data for 4,002 individuals from 2,272
households in Lima, Peru, using a customized Affymetrix Axiom array. The array details, as
well as the genotyping quality control, phasing, and imputation have been described in detail
in a prior publication43; in brief, we designed a ~720K marker array based on exomesequencing data from 116 Peruvians in order to optimize for population-specific rare and
coding variants. Out of 4002 recruited individuals, 22 individuals were excluded during
quality control due to missing more than 5% of the genotype data, excess of heterozygous
genotypes (±3.5 SD), duplicated with identity-by-state>0.9, or TB cases with age-atdiagnosis above 4043. We further excluded 846 individuals from the analysis: individuals
below 19 years of age, individuals without height measurement, and individuals with a
measured height ±3.5 SD away from the population average. The final cohort for the current
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study included 3,134 from 1,947 households. We used GRCh37 as the reference genome for
all our genetic analyses.
Replication cohort: We collected genotyping data for 889 individuals from 273
households in the same population and catchment area as our discovery cohort. We collected
blood using the Whatman® protein saver cards (Dried Blood Spot (DBS) cards) (SigmaAldrich, catalog number: WHA10534320). We extracted genomic DNA from the collected
blood and genotyped all the samples using the Illumina Multi-Ethnic Genotyping Array
(MEGA). rs200342067 is included on the MEGA array and was directly genotyped in all
individuals. We used Plink (version 1.90b3w) to estimate the level of genotyping
missingness and the proportion of heterozygous variants per individual. Height data was not
available for 127 individuals. Moreover, 164 individuals were excluded due to age<19 years
old. The final cohort included 598 individuals from 242 households.

Author Manuscript

Genetic relatedness matrix (GRM) and Kinship estimation
To avoid spurious association results, it is important to account for both recent genetic
relatedness, such as family structure (kinship), and more distant genetic relatedness, such as
population structure. To this end, we used GEMMA46 (version 0.96), with default options, to
generate a GRM after removing rare variants (MAF ≤ 1%), regions with known long-range
linkage disequilibrium (LD)47, and variants in high LD (r2>0.2 in a window of 50kb and a
sliding window of 5kb). We used PLINK (version 1.90b3w) for pruning the genotypes. We
generated a separate GRM following the same steps for the Peruvian individuals that were
included in the replication cohort.

Author Manuscript

Many kinship estimation methods perform under the assumption of sampling from a single
population with no underlying ancestral diversity. Kinship estimates are inflated when this
assumption is violated 48. In the presence of population structure and admixture, methods
that replace population allele frequencies with ancestry-specific allele frequencies are
preferred48. We used PC-Relate49 implemented in the GENESIS R package (version 2.6.1)
to estimate the kinship coefficients between individuals. This method uses ancestry
representative PCs to correct for population structure before calculating the kinship
coefficients. For this analysis, we removed rare variants (MAF<1%), regions with known
long-range linkage disequilibrium (LD)47, and variants in high LD (r2>0.2 in a window
of 50kb and a sliding window of 5kb). Individuals were considered
unrelated if their estimated kinship coefficients were ≤ 0.0625,
corresponding to second-degree genetic relatedness or closer. 476
individuals had kinship coefficients>0.0625.

Author Manuscript

Next, we inferred pairwise IBD segments between the individuals in our cohort using
Refined IBD5. Refined IBD uses a haplotype dictionary to find exact short matches between
phased haplotypes from different individuals and then expand these matches to identify long,
nearly identical IBD segments between these individuals50. Refine IBD then evaluates
candidate IBD segments with a probabilistic approach to assess the strength of evidence for
IBD and reports the segment above a threshold as IBD segments. To calculate IBD segments
using Refined IBD, we first used PLINK (version 1.90b3w)51 on QCed genotypes
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(N=677,675 markers) to generate one VCF file per chromosome. We then used Refined IBD
function5 implemented in Beagle (version 4.1) to phase these genotypes and to calculate
IBD segments in our cohort (N=3,134). We used Refined IBD with nthreads=8,
overlap=3000, default options for other parameters, and genetic maps from HapMap II
(Build GRCh37/hg19) (provided on Beagles website). Finally, we calculate the proportion of
IBD by dividing the length of IBD segments by the length of diploid GRCh37 autosomal
chromosomes excluding GRCh37 gap regions such as centromere (e.g accessible genome,
5.7×109 bp). We used the Pearson correlation coefficient in R (version 3.4) to compare the
GENESIS and Refined IBD results.
The Peruvian Genome Project (PGP)

Author Manuscript
Author Manuscript

In some analyses, we have used whole-genome sequencing data from the Peruvian Genome
Project (PGP)3. This cohort is, previously described by Harris et al, PNAS, 20173, includes
150 Peruvian individuals that were collected separately from our cohort from three different
geographical regions in Peru: Coast (N=46), Amazon (N=28), and Andes (N=76). Assigning
individuals to different Native American groups from the three geographical regions is
described in Harris et al, PNAS, 20173 as follows: “Native American population cohort
participants were recruited from the Matzes, Uros, Afroperuvians, Chopccas, Moches,
Q’eros, Nahuas, and Matsiguenka populations. We applied three criteria to optimize
individuals to best represent the Native American populations: (i) the place of birth of the
participant and that of his or her parents and grandparents, (ii) their last names (only those
corresponding to the region), and (iii) age (eldest to mitigate effects of the last generation).
Participants of the mestizo population cohorts were recruited from the cities Iquitos, Puno,
Cusco, Trujillo, and Lima and were randomly selected. The Afroperuvians were sampled as
a Native American population; however, for all analyses, we treated them as a mestizo group
due to their expected admixture between multiple ancestries.”
rs200342067 allele frequency difference between the coast and non-coastal regions

Author Manuscript

We compared the extent of the allele frequency difference between individuals from the
coastal regions in Peru (N=46) and individuals that were not from the coastal regions in Peru
(N=104) using two-sided Fisher’s exact test (N=9,381,550 variants). Next, to ensure
adequate control for population structure, we used Bayenv2.0 (version 2.0)30 to calculate a
covariance matrix between the coast and non-coast populations using 63,758 SNPs with
MAF>10% in the PGP cohort3 using the default options. We then used Bayenv2.0 (version
2.0)30 to calculate standardized allele frequencies and XTX statistics, a population
differentiation statistic that is designed to detect variant level deviations from the neutral
patterns of population structure while correcting for population structure30, for rs200342067
as well as all the 2,062 SNPs randomly selected SNPs that were matched in MAF and local
recombination rate to rs200342067 using the default options.
Principal Component Analysis (PCA)
To obtain PCs within the LIMAA cohort, we merged our genotype data with data from the
continental populations of phase 3 of the 1000 Genomes Project17 and genotype data from
Siberian and Native American populations from the Reich et al. 2012 Nature study52 by
matching on the chromosome, position, reference, and alternate alleles. After merging the
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datasets, variants with an overall MAF<1% were excluded. We used GCTA53 (version
1.26.0) to perform PCA. We used PLINK (version 1.90b3w)51 for LD pruning, merging, and
quality control. The merged dataset included 34,936 variants.
To ensure adequate control for population structure and differences in ancestry that might
exist within the different geographical regions of Peru, we also calculated PCs of the
LIMAA cohort (N=3,134) projected into the PC space of PGP cohort3 (N=150). To do
this we selected 247,940 common (MAF≥5%) variants that were shared
between the PGP and LIMAA cohorts. We then calculated PCs in the PGP
cohort using the EIGENSOFT (version 6.1.4)54 smartpca function. Finally, we
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used the SNP loadings from the smaptpca analysis to project the individuals from the
LIMAA cohort to the PC space of PGP cohort using the SNPWEIGHTS (version 2.1)
software55. We used ANOVA (R version 3.4) to test the association of the first ten PCs of
PGP cohort with coast-non-coast status. We tested the association between PCs of LIMAA
cohort with Native American ancestry proportion (NAT), height, or rs200342067 minor
allele count using lme4qtl56 (R version 3.4), a linear mixed model framework, with age, and
sex, and a genetic relatedness matrix to account for genetic relatedness (calculated using
GEMMA46, version 0.96) as covariates.
Global ancestry inference

Author Manuscript

We used ADMIXTURE57 (version 1.3) at K=4 clusters, for global ancestry inference. The
choice of four ancestral populations for ADMIXTURE analysis was based on Peru’s
demographic history and previous studies of Peruvian population structure2–4. We used the
merged dataset described above as input for the ADMIXTURE analysis. We used PLINK
(version 1.90b3w)51 to exclude variants with genotyping missingness rate>5% and to
perform LD pruning by removing the markers with r2>0.1 with any other marker within a
sliding window of 50 markers per window and an offset of 10 markers.
Correlation between global ancestry proportions and height

Author Manuscript

We used the R package lme4qtl56, a linear mixed model framework, to measure the
correlation between global ancestry proportions and height. We included the following
covariates in the base model: age, sex, African and Asian ancestry proportions, as well as a
GRM to account for population structure and genetic relatedness generated using PCRelate49 which is implemented in the GENESIS R package (version 2.6.1). We repeated this
analysis after adding a random effect to account for the individual’s household as a proxy for
unmeasured environmental factors. Finally, to ensure adequate control for environmental
factors, we randomly assigned height to individuals within each household 10,000 times and
recalculated the Native American ancestry effect size using the base model to generate an
empirical null distribution. We compared the null distribution with the observed Native
American ancestry effect size from the original data to generate an empirical permutation pvalue.
Common variant association analysis
In the discovery cohort, Imputed SNPs with an imputation quality score r2<0.4, HWE Pvalue<10−5, or a missing rate per SNP>5%. After filtering, 7,756,401 SNPs were left for
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further association analyses. We used GEMMA46 (version 0.96) to perform the single
variant genome-wide association analysis, with age, sex, and a GRM generated using
GEMMA46 (version 0.96) as covariates. We repeated the association for chromosome 15 by
adding one or more of the following covariates: 10 PCs, 20 PCs, socioeconomic status,
African global ancestry proportion, Asian global ancestry proportion, and European global
ancestry proportion. To ensure adequate control for population structure, we also repeated
the association test between height (cm) and rs200342067 with age, sex, 10PCs derived from
projecting the LIMAA cohort into the PC space of PGP cohort3 (see PCA section above for
details), and a GRM generated using GEMMA46 (version 0.96). To ensure that our choice of
GRM does not affect the association between rs200342067 and height, we repeated the
association analysis using two new GRMs. First, a GRM calculated using PC-Relate49, with
age, sex, and 10 principal components as fixed covariates. Second, a GRM calculated using
Refined IBD5 with age, sex, and 10 principal components as fixed covariates. All association
p-values are reported as two sided Wald test p-values.
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To ensure that local (e.g per chromosome) relatedness patterns such as autozygosity
segments do not bias the relatedness, we generated 23 GRMs, leaving one chromosome out
in each GRM using PC-Relate49 and repeated the association for all imputed variants on
each chromosome using a GRM generated without that chromosome. Age, sex, and 10 PCs
were included as additional covariates in this analysis. For the replication analysis in the
Peruvian population, we used the minor allele count information of rs200342067, directly
genotyped on the Illumina MEGA array, from 598 Peruvian individuals (see above for
details about the replication cohort). Similar to the discovery cohort, we tested the
association of rs200342067 with height (cm) using a linear mixed model framework
implemented in GEMMA46 (version 0.96) with age, sex, and a GRM (calculated using
GEMMA) as covariates.
Additional replication cohorts
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PAGE: The PAGE study is a meta-analysis of multiple existing major population-based
cohorts7. The cohorts included in PAGE height study include the BioMe biobank (BioMe),
the Hispanic Community Health Study / Study of Latinos (HCHS/SOL), The Multiethnic
Cohort (MEC), and the Women’s Health Initiative (WHI)7. Height in centimeters was
measured by trained clinic staff in the SOL and WHI studies at the time of enrollment. In
MEC and BioMe height was self-reported by questionnaire. Individuals with height
measurements ±6 standard deviations (SD)) from the mean (based on sex and race),
individuals<18 years of age and women who were pregnant were excluded from the height
GWAS analysis in PAGE. To get comparable phenotypes between different cohorts, PAGE
uses inverse normal transformation of sex-specific height residuals adjusted for age as
dependent variable in a linear mixed model that includes self-identified ancestry, study,
study center, and 10 principal components (measured from unrelated individuals) as fixed
and a genetic relatedness matrix (using GENESIS58) as random effect7. See7 for detailed
information about the phenotype and statistical analysis of the PAGE cohort. We used the
summary statistics from 31,214 Hispanic and Latino individuals from the PAGE study in our
replication analysis.
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GIANT: The Genetic Investigation of ANthropometric Traits (GIANT) consortium exome
array study is a meta-analysis of 147 studies comprising 458,927 adult individuals6. Height
in centimeters was corrected for age and the genomic principal components, as well as any
additional study-specific covariates (e.g. recruiting center), in a linear regression separately
by sex. For family-based studies, sex was included as a covariate in the model. Additionally,
residuals for case/control studies were calculated separately. Similar to the PAGE cohort,
GIANT uses the inverse normal transformation of calculated residuals as the dependent
variable in an ancestry-specific linear mixed model that corrects for cryptic relatedness using
a kinship matrix in each cohort separately followed by a meta-analysis of the results. See6
for detailed information about the phenotype and statistical analysis of the GIANT cohort.
We used the summary statistics from 10,776 Hispanic individuals from the GIANT study in
our replication analysis.
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Meta-analysis
We used the meta R package59 (version 4.9–3) to perform inverse variance-based metaanalysis using summary statistics from the height GWAS in LIMAA discovery cohort and
the Peruvian replication cohort in which the measured phenotype was the height in cm. To
perform meta-analysis using the GIANT6 and PAGE7 cohorts we repeated our association
analysis in both the discovery and the replication cohorts as described above with age, sex,
and a GRM generated using GEMMA46 (version 0.96) as covariates and inverse normally
transformed height as the dependent variable. We used summary statistics from these
analyses as well as summary statistics form the GIANT6 and PAGE7 cohorts to perform
Inverse variance-based meta-analysis using the meta R package59.
Heritability analysis

Author Manuscript

We used GREML analysis in GCTA60 (version 1.26.0) to calculate the amount of variance in
height explained by all common variants (MAF>1%). We included 423,108 variants from
2,667 unrelated individuals in this analysis with age, sex, and the first 10 PCs as covariates
in the analysis. To calculate height heritability in each sex, we repeated the heritability
analysis in men and women separately.
Polygenic risk score (PRS) analysis
Out of 3,290 independent genome-wide significant variants reported by Yengo et al8, 2,993
were present in our cohort. We constructed polygenic risk scores (PRSs) for each individual
using height-increasing effect sizes of these 2,993 previously published height-associated
variants8 as follows:

Author Manuscript

m
P RSi = Σi − 1 nij ∗ Bj

Where βi is the reported conditional effect size for variant i in the European population, nij is
the allele count of variant i in individual j in our Peruvian cohort, and m is the total number
of variants used in the construction of the PRS. We calculated the amount of variance
explained (r2) using lm function in R (version 3.4) with height residuals adjusted for age,
sex, and a GRM generated using GEMMA46 (version 0.96) to account for relatedness and
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cryptic population structure as the dependent variable and PRS as the explanatory variable.
Out of 3,290 independent genome-wide significant variants reported by Yengo et al8, 2,388
reached genome-wide significance in unconditional analysis. We repeated the PRS
calculation using the unconditional effect sizes of 2, 195 of these variants that were also
present in our cohort. We used the cocor package in R (version 1.1–3) to test the significance
of the difference between the amount of variance explained using different PRS.
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For the sex-specific analysis, we first calculated height residuals in each sex separately after
adjustment for age and a GRM generated using GEMMA46. We then calculated the r2 using
lm(), with height residuals as the dependent variable and PRS as the explanatory variable for
each sex separately. For the analysis in individuals with high or low European ancestry
proportions, we separated the cohort to individuals with high European ancestry proportions
(top quartile) and low European ancestry proportions (1st, 2nd, and 3rd quartile) and
calculated height residuals after adjustment for age, sex, and a GRM generated using PCRelate49 to account for relatedness but not population structure. We then calculated the r2
using lm function, with height residuals as the dependent variable and PRS as the
explanatory variable in each group separately.
Gene-based association analysis
We used SKAT61 (version 1.3.2.1) for gene-based association testing of rare (MAF<1%)
variants. Null distributions were generated using SKAT_NULL_emmaX, which incorporates
kinship structure in the calculation of SKAT parameters and residuals. Age and sex were
included as covariates. The statistical significance threshold was set at p-value<2.5×10−6
which is the Bonferroni correction threshold for 20,000 proteincoding genes. For common variants (MAF≥1%) we used fastBAT analysis

Author Manuscript

in GCTA62 to perform gene-based association testing using GWAS summary statistics.

Positive selection analyses
Integrated Selection of Allele Favored by Evolution (iSAFE)20: We used
SHAPEIT2 (version v2.r837) to phase the imputed genotypes for chromosome 15 for all the
individuals in our cohort (N=3,134). We then used iSAFE (version v1.0.4) software,
available at https://github.com/alek0991/iSAFE with the following options MaxRank=300,
MaxFreq=0.85, and enabling IgnoreGaps flag to detect variants under positive selection in a
1.2Mb window around rs200342067.
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Extended haplotype homozygosity (EHH)21: We used selscan63 (version 1.2.0a) to
calculate EHH in our cohort (N=3,134) or in the simulated data. The analysis was restricted
to variants with MAF>1%. For all variants, including rs200342067, we calculate EHH in a
2Mb window around the variant. For EHH, we interpolated the genetic position based on the
average recombination rate of the chromosome to get a comparable measure of haplotype
length between positively selected regions, regions under neutral selection, and simulated
data. To ensure that the EHH calculation at rs200342067*C is not biased due to selection at
the nearby selected locus rs12441775*G, we repeated the EHH calculation for at
rs200342067*C after removing the nine haplotypes that harbored both rs200342067*C and
rs12441775*G (update MAF for rs200342067*C=4.6%). For integrated EHH values we

Nature. Author manuscript; available in PMC 2020 August 06.

Asgari et al.

Page 15

Author Manuscript

calculated the area under the EHH curve. The global map of rs12441775*G was generated
using the Geography of Genetic Variants (GGV) browser64 at: http://
www.popgen.uchicago.edu/ggv
Comparing EHH of rs200342067 with similar variants under neutral
selection: We selected 2,380 variants that were overlapping the previously published
putative neutral regions of the genome23 and had similar DAF to rs2003420678*C allele in
our cohort (4.7±1 %). We calculated EHH for these variants using selscan63 (version 1.2.0a)
and compared the EHH decay plots as well as the integrated EHH values for
rs2003420678*C and these variants. In a second step we removed the nine haplotypes
carrying rs12441775*G from our cohort and repeated the EHH analysis using 2,309 variants
that were overlapping the previously published putative neutral regions of the genome23 and
had similar DAF to the updated frequency of rs2003420678*C allele (AF=4.6±1 %).
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Selecting variants in the same derived allele frequency (DAF) and
recombination bin as rs200342067: We restricted the analysis to biallelic variants, the
ancestral allele was assigned using the “Ancestral allele” information provided in the 1000
Genomes Project17. We calculated the derived allele frequency of each common variant
(MAF>1%) in the Peruvians from the 1000 Genomes Project17 (N=85). We also interpolated
the genetic position of each common variant (MAF>1%) using the 1000 Genomes Project17
phase 3 genetic maps. The recombination rate was calculated as follows: genetic position
(cM) / physical position (Mb). Variants on each chromosome were divided into 100 DAF
bins, and 20 recombination bins. The DAF for rs200342067 in the Peruvians from the 1000
Genomes Project17 is 4.1% (DAF bin 4) and its recombination rate is 1.4 (recombination bin
5). For comparison with rs200342067, we selected 2,062 variants that were in the same DAF
and recombination bin as rs200342067 and that was at least 1Mb apart (e.g independent).
Integrated Haplotype Score (iHS)18: iHS values for the Peruvians and other
populations from the 1000 Genomes Project17 were obtained from a previously published
study by Johnson and Voight, 201819. Full dataset available at: http://
coruscant.itmat.upenn.edu/data/JohnsonEA_iHSscores.tar.gz.
Testing the extent of rs200342067 MAF difference between the coastal and non-coastal
regions
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Fisher’s Exact test: We used minor allele counts for rs200342067 as well as 2,062
independent variants matched in DAF and local recombination rates to rs200342067 (see
above) in populations from the coastal regions (N=46) or non-coastal regions (e.g Andes and
Amazon, N=104) of the Peruvian Genome Project cohort3, to perform Fisher’s exact test in
R (version 3.4).
XTX analysis: We used Bayenv2.030 to calculate a covariance matrix between the coast
and non-coast populations using 63,758 SNPs with MAF>10% in the PGP cohort 3. We then
used Bayenv2.030 to calculate standardized allele frequencies and XTX statistics for
rs200342067 as well as all the 2,062 SNPs randomly selected SNPs that were matched in
DAF and local recombination rate to rs200342067.
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We used msprime (version 0.7.3)65, a coalescent model with recombination, to simulate
2000 Peruvian individuals with the recombination map from HapMap Project66 1000 times.
We adapted and constructed the population structures from out of Africa model proposed by
Gravel et al67 with parameters previously inferred from 1000 Genomes Project17. To mirror
the Peruvian migration history, we created a three-way admixture event around 500 years
(25 generations) ago. We used the 1000 Genomes Project 17 phase 3 genetic maps for
chromosome 15 to interpolated the recombination rate of in our simulation. We set the
admixture to have 80% Native American, 16% European, and 4% African ancestry, inferred
from the LIMMA cohort. We compared the integrated EHH values for 1000 simulated
variants that had similar DAF to rs200342067 (DAF=4.7±1 %) and were overlapping the
same region on the simulated chromosome (physical position 48773926±20kb) with the
integrated EHH value of rs200342067 in our cohort (N=6,628 haplotypes). We repeated the
analysis for two putative neutral regions on the chromosome 15 in the simulated data
(N=2,000 haplotypes) and compared the integrated EHH values with the integrated EHH
values for two variants, rs17580697 (DAF=4.6%) and rs305008 (DAF=4.6%), which are
overlapping these neutral regions of chromosome 1523 in our cohort (N=6,628 haplotypes).
Mutation age
We used the pre-calculated mutation age estimates based on the 1000 Genomes Project
populations17 from the human genome dating server (https://human.genome.dating/,
accessed December 2019)25.
FBN1 cbEGF-domain 17, 3D structure
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The 3D structure was obtained based on homology with fibrillin-1 cbEGF-domains 12 and
13, 1LMJ, previously published by Smallridge et al, J Biol Chem 200336 in the Protein Data
Bank (PDB).
Clinical examination
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Clinical examination was approved by the local Institutional Review Board (IRB).
Individuals with T/T genotype (controls) were matched with cases (individuals with C/C and
C/T genotypes) for sex, age±5 years, Native American ancestry proportion±0.05, and
European ancestry proportion±0.05. A board-certified rheumatologist performed a
musculoskeletal exam and history, including a detailed musculoskeletal history with review
of systems, past medical history, medication history, social history, and family history; vital
signs; range of motion on knees, wrists, elbows, index fingers, middle fingers, and hips; joint
exam of hands for bony changes, synovitis or other abnormalities; joint exam of knees, feet,
and spine for instability, bony changes, inflammation or other abnormalities. A boardcertified dermatologist performed a standardized total body skin exam. This includes an
examination of the skin of the face, eyelids, ears, scalp, neck, chest, axillae, abdomen, back,
buttocks, genitalia, upper extremities, lower extremities, hands, feet, digits, nails, lips,
mouth, mucosae, and lymph nodes. We also obtained skin biopsies for two individuals with
C/C genotype and two age, sex, and ancestry matched individuals with T/T genotype
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patients at 5cm lateral to the umbilicus (in clinically normal skin) to assess histologic
differences associated with genotype.
Histology
Following Harvard Medical School Institutional Review Board Approval, samples were
obtained by skin punch biopsy performed as per routine by a Massachusetts General
Hospital (MGH) dermatologist and placed into specimen jars containing 10% neutral
buffered formalin. The specimens were shipped via courier to MGH at ambient temperature,
placed into tissue cassettes, processed routinely, and paraffin-embedded tissue blocks were
prepared at the Histopathology Research Core of the Massachusetts General Hospital. One
hematoxylin & eosin (H&E) stained glass slide was prepared for each block and additional
unstained 5 micrometer thick sections cut from the tissue blocks were placed onto Fisher
superfrost slides (protein-coated).
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Immunohistochemical Analysis
Anti-fibrillin 1 antibody staining was performed using citrate buffer antigen retrieval
technique. Appropriate negative control sections (primary antibody omitted to monitor for
background staining) and positive control sections (human placental tissue known to express
the antigen, as recommended by the manufacturer) were evaluated. Tissue sections were
manually stained with rabbit polyclonal anti-fibrillin 1 antibody (FBN1, dilution 1:250,
HPA021057, MilliporeSigma, St. Louis, MO) and counterstained with hematoxylin
following deparaffinization of 5 micrometers cut sections. Antigen expression was assessed
by a board-certified pathologist in dermal fibroblasts for each specimen in a blinded fashion.
Electron Microscopy on Formalin Fixed Paraffin Embedded Tissues
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Areas of interest were identified on H&E stained slides and matched to the corresponding
paraffin blocks. Under a dissecting microscope these areas were cut out using a sharp razor
blade and placed into glass vials containing 100% xylene. The vials were left overnight at
room temperature and the xylene changed the following morning. The vials were then left
gently rotating for an additional three hours before rehydrating for one hour each in a series
of ethanol (100%, 95%, 70%, 50%, and 25%) solutions. Tissues were then rinsed in sodium
cacodylate buffer and fixed for 1.5 hours with our routine glutaraldehyde fixative (2.5%
GTA, 2.0% PFA, 0.025% calcium chloride, in a 0.1M sodium Cacodylate buffer pH 7.4).
Tissues were further processed in a Leica Lynx automatic tissue processor. Briefly, tissues
were post fixed with osmium tetroxide, dehydrated in a series of ethanol solutions, en bloc
stained during the 70% ethanol dehydration step for one hour, infiltrated with propylene
oxide epoxy mixtures, embedded in pure epoxy, and polymerized overnight at 60°C. Thick
sections were cut and stained with toluidine blue and examined with a light microscope.
Thin sections were cut from representative areas, stained with lead citrate and examined
with an FEI Morgagni transmission electron microscope. Images were captured with an
AMT (Advanced Microscopy Techniques) 2K digital CCD camera.
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To investigate whether rs200342067 or the other four variants in linkage with it our cohort
can act as an enhancer for SLC24A5, we investigated ENCODE’s H3K27ac marks to search
for active enhancer’s overlapping these variants (data accessed on 08.22.2019 from the
ENCODE portal) as well as Hi-C data in published cell types68–70 for evidence of physical
interaction between these variants and SLC24A5 (3D Genome Browser data accessed on
08.22.2019 from http://promoter.bx.psu.edu/hi-c/view.php).

Extended Data
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Extended Data Figure 1:
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A and B) PCA analysis of genotyping data from Peruvians included in this study (N=3,134
individuals) merged with the data from continental populations from the 1000 Genomes
Project phase 3 (N=3469 individuals) as well as the data from Siberian and Native American
populations from Reich et al. 2012 Nature study (N=738 individuals) as reference panel
(number of variants=34,936). Dots: individuals, color: populations (AFR: Africa, AMR:
South America, EAS: East Asia, SAS: South Asia, EUR: Europe, SIB: Siberian, NAT:
Native American). C) Global ancestry analysis using ADMIXTURE (K=4). We observed
varying levels of European, African, and Asian admixture in our cohort (N=3,134
individuals) with a median proportion of Native American, European, African, and Asian
ancestry per individual of 0.83 (Interquartile range (IQR)=0.72–.91), 0.14 (0.08–0.21), 0.01
(0.003–0.03), and 0.003 (10−5–0.01) respectively. Vertical lines: individuals, colors:
genomic proportion of a given ancestry in an individual’s genome. ADMIXTURE analysis
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(K=4) is done using all populations in 1000 Genomes Project phase 3 as well as Siberian
and Native American populations from the Reich et al. 2012 Nature study as reference.
AFR: African ancestry includes: Yoruba in Ibadan, Nigeria, Luhya in Webuye, Kenya,
Gambian in Western Divisions in the Gambia, Mende in Sierra Leone, Esan in Nigeria,
Americans of African Ancestry in SW USA; EUR: European ancestry, includes: Central
European, Utah Residents (CEPH) with Northern and Western European Ancestry, Toscani
in Italy, Finnish in Finland, British in England and Scotland, Iberian Population in Spain;
EAS: East Asian, includes: Han Chinese in Beijing, China, Japanese in Tokyo, Japan,
Southern Han Chinese, Chinese Dai in Xishuangbanna, China, Kinh in Ho Chi Minh City,
Vietnam; SAS: South Asian, includes: Gujarati Indian from Houston, Texas, Punjabi from
Lahore, Pakistan, Bengali from Bangladesh, Sri Lankan Tamil from the UK, Indian Telugu
from the UK; PUR: Puerto Ricans from Puerto Rico; CLM: Colombian from Medellin,
Colombia; MXL: Mexicans from Los Angeles, California; PEL: Peruvians from Lima, Peru.
Altic: Altaic language family, includes: Yakut, Buryat, Evenki, Tuvinians, Altaian,
Mongolian, Dolgan. North Amerind: Northern Amerindian language family, includes: Maya,
Mixe, Kaqchikel, Algonquin, Ojibwa, and Cree. Central Amerind: Central Amerindian
language family, includes Pima, Chorotega, Tepehuano, Zapotec, Mixtec, and Yaqui.
Andean: Andean language family, includes: Quechua, Aymara, Inga, Chilote, Diaguita,
Chono, Hulliche, and Yaghan. For a full list of all populations in all language groups see the
Reich et al. 2012 Nature study.
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Extended Data Figure 2: Association of rs200342067 and height.
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A) Single variant association analysis (N=3,134 individuals and 7,756,401 variants), dotted
red line: genome-wide significance threshold of 5×10−8. Five SNPs overlapping the coding
sequence of FBN1, passed the genome-wide significance threshold. We did not observe any
inflation in test statistics (λ=1.02). Association p-values are two-sided Wald test p-values.
B) rs200342067 in heterozygous individuals reduces height by 2.2 cm (4.4 cm in
homozygous individuals, including 11 individuals with C/C genotype, 275 C/T genotype,
and 2,848 T/T genotype) and could explain 0.9% of height phenotypic variance in our cohort
(N=3,143 individuals). x-axis: rs200342067 genotype, y-axis: height residuals after
adjustments for age, sex, and a GRM as random effect.
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Extended Data Figure 3: rs12441775 derived allele frequency (DAF, rs12441775*G) and
extended haplotype structure in the 1000 Genomes Project.
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A) The derived allele, rs12441775*G, have a high frequency in all non-African populations
in the 1000 Genomes Project (average DAF in non-Africans=58% IQR=51–64 and in
Africans=4% (1–5)). The Map is generated using the Geography of Genetic Variants (GGV)
browser, see Marcus and November, 2016, Bioinformatics study and http://
www.popgen.uchicago.edu/ggv. B–H) Haplotypes carrying rs12441775*G (major/derived)
are longer than haplotypes carrying rs12441775*C (minor/ancestral) in the non-African
population. Horizontal lines: haplotypes, rs12441775’s position is marked above the
haplotype. At any given position, adjacent haplotypes with the same color carry identical
genotypes between the core SNP (rs12441775) and the that site, dashed line separates the
haplotypes carrying the derived (above the line) and ancestral (below the line). SAS: South
Asian, EUR: European, EAS: East Asian, AFR: African, AMR: American, PEL: Peruvians
from Lima, Peru.
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Extended Data Figure 4: Haplotypes carrying rs200342067 are longer than what is expected
under neutral selection.
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A) Haplotype decay around rs200342067 in our cohort (N=6,268 haplotypes). The
rs200342067’s position is marked above the haplotype, haplotypes above the dashed line are
the haplotypes carrying rs200342067*C (derived/minor, N=297 haplotypes) and haplotypes
under the dashed line are the haplotypes carrying rs200342067*T (ancestral/major, N=5,971
haplotypes). B) Integrated Extended Haplotype Homozygosity (integrated EHH) for
haplotypes carrying rs200342067*C (N=297 haplotypes) compared to integrated EHH for
haplotypes carrying 2,380 variants with similar DAF (4.7±1%) that are overlapping the
neutral regions of the genome in our cohort (N=3,134 individuals). Haplotypes carrying
rs200342067*C are longer than 99.2% of the haplotypes in neutral regions of the genome.
Vertical red line: integrated EHH for haplotypes carrying rs200342067*C (integrated
EHH=0.115). C) The same as A excluding the nine haplotypes that carry both
rs200342067*C and rs12441775*G alleles. D) EHH decay curves for haplotypes carrying
rs200342067*C excluding the nine haplotypes that carry both rs200342067*C and
rs12441775*G (N=288 haplotypes) compared to haplotypes carrying 2,309 variants that
have similar DAF to the updated frequency of rs200342067*C (4.6±1%) and are overlapping
the neutral regions of the genome in our cohort (N=3,134 individuals). Haplotypes carrying
rs200342067*C are longer than 99.7% of the haplotypes in the neutral genomic regions. E)
Integrated EHH for haplotypes shown in D. Vertical red line: integrated EHH for haplotypes
carrying rs200342067*C but not rs12441775*G (integrated EHH=0.124).
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Extended Data Figure 5: Simulation of haplotypes under neutral demographic model.
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A) PCA plot of simulated individuals (N=1000 simulated individuals and 2000 simulated
haplotypes). Individuals were simulated using a demographic model matching Peru’s
population history and under neutral selection. red dots: simulated individuals, other dots:
reference populations from the 1000 Genomes project. B) We compared rs200342067*C’s
integrated EHH with integrated EHH of 1000 variants that had similar DAF to rs200342067
(DAF=4.7±1%) and were overlapping the same genomic region as rs200342067 on
simulated chromosome 15 (physical position 48773926±20kb). rs200342067’s integrated
EHH is more extreme than integrated EHH observed for any of the variants in the simulated
data. x-axis: integrated EHH, distribution: integrated EHH of variants in simulated
haplotypes (N=2000 haplotypes), vertical red line: integrated EHH value of rs200342067 in
our cohort (N=6,628 haplotypes, integrated EHH=0.115). C and D) Similar to A for two
different neutral regions on chromosome 15. vertical red lines: integrated EHH of
rs17580697 (C, integrated EHH=0.012, 76th percentile) and rs305008 (D, integrated
EHH=0.010, 74th percentile) in our cohort (N=6,628 haplotypes).
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Extended Data Figure 6: Comparison of different selection statistics for rs200342067 and other
variants with similar DAF and recombination rate.
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A) Distribution of iHS for 2,062 independent (at least 1Mb apart) variants matched in DAF
and local recombination rate to rs200342067. iHS values are calculated for Peruvian
individuals in the 1000 Genomes Project (N=85 individuals) and were obtained from
Johnson and Voight, 2018, Nature Evolution and Ecology, study. red line: rs200342067’s
iHS (iHS=−1.5, 4.7th percentile), green and blue lines: 5th and first percentile of iHS
distribution. B) EHH decay curves for rs200342067 (red line) as well as haplotypes carrying
2,062 independent variants (at least 1Mb apart) matched in DAF and local recombination
rate to rs200342067 in our cohort (N=6,268 haplotypes (gray lines). C) Distribution of
integrated EHH for haplotypes shown in B, haplotypes carrying rs200342067*C are longer
than 97.5% of haplotypes carrying similar variants. x-axis: integrated EHH, red line:
integrated EHH for rs200342067*C allele (integrated EHH=0.115). D) Histogram of
Fisher’s exact test results comparing the extent of allele frequency differences between
coastal (N=46 individuals) and non-coastal (N=104 individuals) regions in Peru for 2,062
independent variants that were matched in DAF and local recombination rate to
rs200342067. x-axis: -log10 of two-sided Fisher’s exact test p-value, dashed blue and green
vertical lines: 99th and 95th percentiles respectively, solid red line: -log10 of two-sided
Fisher’s exact test p-value for rs200342067 (1.1% percentile, two-sided Fisher’s exact test pvalue=0.0005). E) Bayenv2.0 XTX statistics, a measure of deviation from neutral patterns of
population structure, for 2,062 independent variants that were matched in DAF and local
recombination rate to rs200342067. x-axis: XTX statistics, red line: XTX value for
rs200342067 (XTX= 2.13, 8.3th percentile), green and blue lines: 5th and first percentile of
XTX distribution respectively.
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Extended Data Figure 7: Genomic context of rs200342067 (E1297G).
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A) Schematic representation of FBN1, exons are shown as black bars. Exon 31
(ENSE00001753582) is shown in red. B) FBN1 exon 31 sequence and PhyloP pernucleotide conservation score based on multiple sequence alignment of 100 vertebrate
species (obtained from UCSC genome browser GRCh37 assembly conservation track). The
T>C change due to rs200342067 occurs in a conserved nucleotide. C) Schematic
representation of Fibrillin-1 (ENST00000316623.5). Fibrillin-1 consists of the following
domains: N and C terminal (black rectangles), EGF-like domains (stripped rectangles),
hybrid domains (black pentagons), TGFβ-binding domains (gray ovals), a proline-rich
domain (white hexagon), and 43 calcium binding cbEGF-like domains (white rectangles).
cbEGF-domain 17, the domain affected by rs200342067 (E1297G), is shown in red, E1297G
is located between a conserved cysteine (p.Cys1296) involved in forming a disulfide bond
with p.Cys1284 and a conserved asparagine (p.Asp1298) involved in calcium binding. D)
Fibrillin-1 cbEGF-domain 17 sequence and 3D structure of cbEGF-domains 17 and 18 (the
3D structure was obtained based homology with fibrillin-1 cbEGF-domains 12 and 13
previously published by Smallridge et al, J Biol Chem 2003 (1LMJ in the Protein Data
Bank). rs200342067 changes glutamic acid, a large amino acid with a negatively charged
side chain, to glycine, the smallest amino acid with no side chain (shown in red). The side
chains are shown for rs200342067 (red spheres), the calcium-interacting residues (beige
sticks), and the cysteine residues involved in disulfide bonds (yellow sticks). Calcium ion is
shown in green.
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Extended Data Figure 8: Immunohistochemical staining of fibrillin-1.

A–B) Fibrillin-1 staining in skin biopsies in two individuals with rs200342067 C/C genotype
and C–D) two individuals with T/T genotype matched for age, sex, and ancestry
proportions. Individuals with C/C genotype have less fibrillin-1 deposition in the dermal
extracellular matrix (ECM) and shorter microfibrillar projections from the dermal-epidermal
junction into the superficial (papillary) dermis (red arrows, 20x) as well as less fibrillin-1
deposition in the deeper dermis. Two magnification have been shown, the red rectangles in
the first column (20x magnification) are magnified in the second column (60x).
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Extended Data Figure 9: Electron microscopy (EM) of fibrillin-1 in skin.

A–C) EM of the dermal-epidermal junction in two individuals with rs200342067 T/T
genotype B–D) and two individuals with rs200342067 C/C genotype which are matched for
age, sex, and ancestry proportions. Individuals with C/C genotype have short, fragmented,
and less densely packed microfibrils with irregular edges (red arrows) and their microfibrils
are embedded in less dense collagen bundles (yellow arrows) compared to the individuals
with T/T genotype. Two magnification have been shown, the white rectangles in the first
column (4400x magnification) are magnified in the second column (11000x).
Extended Data Table 1:

SNPs overlapping 15q15–21.1 locus.
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In our height GWAS (N=3,134 individuals) one locus reached the genome-wide significance
threshold (p-value<5×10−8). This locus overlaps FBN1 on chromosome 15 and includes five
tightly linked SNPs. One SNP, rs200342067, is a missense variant and the other four are
intronic variants. Association p-values are two-sided Wald test p-values. Numbers are
rounded to two decimal places. se: standard error.
rs

position

allele1

allele2

MAF (%)

effect size (cm)

se

z-score

Wald p-value

rs193211234

48752674

A

T

4.66

−2.37

0.38

−6.24

4.4×10−10

rs200342067

48773926

C

T

4.72

−2.22

0.36

−6.17

6.8×10−10

rs544786245

48822780

T

G

−2.32

0.38

−6.11

1 ×10−9

rs143730951

48858921

T

C

−2.27

0.37

−6.14

8.2×10−10

rs180913076

48928052

C

A

−2.22

0.38

−5.84

5.2×10−9

4.46
4.72
4.56
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Figure 1: Genetic architecture of height in the Peruvian population.
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A) Height is negatively correlated with Native American ancestry proportion (N=3,134
individuals, Pearson’s r=−0.28, CI=−0.31 −0.25, t-value = −16.36, degrees of freedom (df) =
3132, one-sample t-test two-sided p-value=9.3×10−58). Point: median for a decile of Native
American ancestry (x-axis) and the average height for that decile (y-axis). Error bars: range
(x-axis) and standard error (se, y-axis). B) Increased Native American ancestry is associated
with lower height after adjusting for age, sex, African and Asian ancestry proportions,
household as a proxy for socioeconomic factors, and genetic relatedness (N=3,134
individuals). *Household effect size is calculated as the standard deviation (sd) in the
model’s intercept. The effect sizes for African, Asian, and Native American ancestry are
given relative to European ancestry. P-values are two-sided p-values from χ2 difference test.
C) Locus-specific Manhattan plot of -log10 transformed GWAS p-values. One locus on
chromosome 15 passed the genome-wide significance threshold (p-value<5×10−8, N=3,134
individuals). P-values are two-sided Wald test p-values. Dots: variants colored according to
their LD with rs200342067 (total number of variants tested=7,756,401, number of variants
shown=3,176). D) rs200342067 showed a similar MAF, direction of effect, and effect size in
an independent cohort of Peruvians (N=598 individuals), and two independent cohorts of
Latino/Hispanics (N=31,214 and 10,776 individuals respectively). Squares: rs200342067’s
effect size on inverse normally transformed height, dashed blue line: meta-analysis effect
size, diamond: meta-analysis se, error bars: 95% CI. Cohort’s size and rs200342067’s MAF
is shown in parentheses and effect sizes (CIs) on the right. E) Height is positively correlated
with polygenic risk scores (PRS) (N=3,134 individuals, Pearson’s r=0.22, CI=0.18–0.25, tvalue = 12.36, df = 3132, one-sample t-test two-sided p-value=2.7×10−34). Points: median
for a PRS decile (x-axis) and the average height for that decile (y-axis). Error bars: range (xaxis) and se (y-axis).
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Figure 2: rs200342067 is positively selected in the Peruvian population.
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A) Conditional effect sizes and allele frequencies of 3,290 previously identified heightassociated variants in the European population (N ~ 700,000 individuals, green dots)
compared with the effect size and allele frequency of rs200342067 (red diamond) from this
study (N=3,134 individuals, MAF=4.7%). Effect sizes are shown as the absolute effect size
on invers normally transformed height. B) iSAFE plot for a 1.2Mb region around
rs200342067 in our cohort (N=3,134 individuals). x-axis: physical position, y-axis: iSAFE
score. Dots: variants colored according to their LD with rs12441775 (red diamond); Red,
cyan, and blue vertical lines: physical position of rs200342067, rs12441775, and rs1426654
respectively. C) Haplotype decay around rs12441775 in our cohort (N=3,134 individuals).
rs12441775’s position is marked above the haplotype, haplotypes above the dashed line
carry rs12441775*G (derived/major, N=4,063 haplotypes) and haplotypes below the dashed
carry rs12441775*C (ancestral/minor, N=2,205 haplotypes). D) Stacked barplot of
haplotypes carrying rs200342067, rs12441775, and rs1426654 in our cohort (N=6,268
haplotypes). Only 3% of the haplotypes carrying rs200342067*C allele (red arrow) also
carry rs12441775*G allele (AF=64.8%) and only 4% carry rs1426654*A (AF=17.9%). xaxis: SNPs, y-axis: haplotypes carrying derived or alternate allele of rs200342067,
rs12441775, and rs1426654. E) Extended Haplotype Homozygosity (EHH) plots for
haplotypes carrying the rs200342067*C (red line, N=297 haplotypes) compared to
haplotypes carrying 2,380 variants that are overlapping the neutral regions of the genome
and have similar DAF to rs200342067*C (4.7±1%, gray lines). Haplotypes carrying
rs200342067*C are longer than 99.2% of the haplotypes in the neutral genomic regions. F)
Histogram of Fisher’s exact test results comparing the extent of allele frequency differences
between coastal (N=46 individuals) and non-coastal (N=104 individuals) regions in Peru. xaxis: -log10 p-value of two-sided Fisher’s exact test (N=9,381,550 variants), dashed blue
line: 99th percentile, solid red line: rs200342067’s -log10 p-value (0.7th percentile, Fisher’s
exact test two-sided p-value=0.0005); y-axis: variant count in millions.
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Figure 3: Fibrillin-1 electron microscopy (EM) in the skin.

A–C) EM of the dermal-epidermal junction in two individuals with rs200342067 T/T
genotype and B–D) two individuals with rs200342067 C/C genotype which are matched for
age, sex, and ancestry proportions. Individuals with C/C genotype have short, fragmented,
and less densely packed microfibrils with irregular edges (red arrows) and their microfibrils
are embedded in less dense collagen bundles compared to the individuals with T/T genotype.
Magnification: 11000x.
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Table 1:

Replication of rs200342067 association.
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We replicated the association between rs200342067 and height in an independently collected cohort (N=598
individuals). We also tested the association of rs200342067 with inverse normally transformed height in two
publicly available datasets of Hispanic/Latino individuals (PAGE and GIANT, N=31,214 and 10,776
individuals respectively) and observed a similar direction of effect and effect size in these independent cohorts.
P-values are two-sided Wald test p-values. Numbers are rounded to two decimal places.
phenotype

Height in cm

cohort

N

rs

allele1

allele2

MAF
(%)

effect
size

se

z-score

Wald pvalue

Discovery

3,134

rs200342067

C

T

4.72

−2.22

0.36

−6.17

6.8×10−10

Replication

598

rs200342067

C

T

4.52

−1.70

0.82

−2.07

0.04

−2.14

0.33

−6.48

9.2×10−11

Metaanalysis
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3,134

rs200342067

C

T

4.72

−0.25

0.04

−6.25

4.1×10−10

Replication

598

rs200342067

C

T

4.52

−0.20

0.10

−2.00

0.05

PAGE

31,214

rs200342067

C

T

0.37

−0.12

0.07

−1.71

0.09

GIANT

10,766

rs200342067

C

T

1.15

−0.44

0.22

−2.00

0.05

−0.22

0.03

−6.81

9.8×10−12

Discovery

inverse normally
transformed
height

Metaanalysis
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